111 related articles for article (PubMed ID: 18819144)
21. Direct stenting in the DES era: Can we do better?
Bass TA
Catheter Cardiovasc Interv; 2007 Oct; 70(4):513-4. PubMed ID: 17896409
[No Abstract] [Full Text] [Related]
22. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.
Nakazawa G; Vorpahl M; Finn AV; Narula J; Virmani R
JACC Cardiovasc Imaging; 2009 May; 2(5):625-8. PubMed ID: 19442951
[No Abstract] [Full Text] [Related]
23. NEVO™: a new generation of sirolimus-eluting coronary stent.
Falotico R; Parker T; Grishaber R; Price S; Cohen SA; Rogers C
EuroIntervention; 2009 Dec; 5 Suppl F():F88-93. PubMed ID: 22100684
[No Abstract] [Full Text] [Related]
24. A critical appraisal of the Janus carbostent.
Kornowski R
Catheter Cardiovasc Interv; 2009 Feb; 73(2):249-50. PubMed ID: 19156897
[No Abstract] [Full Text] [Related]
25. The artisan approach for stenting bifurcation lesions.
Colombo A; Latib A
JACC Cardiovasc Interv; 2010 Jan; 3(1):66-7. PubMed ID: 20129571
[No Abstract] [Full Text] [Related]
26. A generation 2.5 drug-eluting stent?
Ellis SG
JACC Cardiovasc Interv; 2009 Oct; 2(10):986-8. PubMed ID: 19850259
[No Abstract] [Full Text] [Related]
27. Long-term follow-up of drug-eluting stents placed in the setting of ST-segment elevation myocardial infarction.
Ziada KM; Charnigo R; Moliterno DJ
JACC Cardiovasc Interv; 2011 Jan; 4(1):39-41. PubMed ID: 21251627
[No Abstract] [Full Text] [Related]
28. Drug-eluting stent endothelium: presence or dysfunction.
van Beusekom HM; Serruys PW
JACC Cardiovasc Interv; 2010 Jan; 3(1):76-7. PubMed ID: 20129573
[No Abstract] [Full Text] [Related]
29. "Crying fire in a theater" or a "confirmatory sighting?".
Ellis SG
J Am Coll Cardiol; 2007 Jul; 50(3):268-9. PubMed ID: 17631220
[No Abstract] [Full Text] [Related]
30. Optical coherence tomography to diagnose under-expansion of a drug-eluting stent.
Motreff P; Souteyrand G
JACC Cardiovasc Imaging; 2009 Feb; 2(2):245-6; author reply 246. PubMed ID: 19356563
[No Abstract] [Full Text] [Related]
31. The gender paradox.
Presbitero P
EuroIntervention; 2009 Jan; 4(4):415, 417. PubMed ID: 19284061
[No Abstract] [Full Text] [Related]
32. Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?
Finn AV; Nakazawa G; Kolodgie FD; Virmani R
JACC Cardiovasc Interv; 2009 Apr; 2(4):300-2. PubMed ID: 19463440
[No Abstract] [Full Text] [Related]
33. The process of bringing new drug-eluting stents to market will they see the light of day?
Holmes DR; Patel M
JACC Cardiovasc Interv; 2008 Oct; 1(5):533-4. PubMed ID: 19463355
[No Abstract] [Full Text] [Related]
34. A ticking time bomb?: a case report of very late stent thrombosis more than 2 years after fracture of a Cypher stent.
Ong SH; Mueller R; Boekstegers P
Clin Res Cardiol; 2011 Oct; 100(10):951-3. PubMed ID: 21725857
[No Abstract] [Full Text] [Related]
35. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
[TBL] [Abstract][Full Text] [Related]
36. Another small step for small vessels.
Morrison DA
Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
[No Abstract] [Full Text] [Related]
37. Nevo stent: a successful stent makeover.
Belardi JA
Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
[No Abstract] [Full Text] [Related]
38. A randomized comparison of sirolimus-eluting versus bare metal stents in the treatment of diabetic patients with native coronary artery lesions: the DECODE study.
Chan C; Zambahari R; Kaul U; Lau CP; Whitworth H; Cohen S; Buchbinder M;
Catheter Cardiovasc Interv; 2008 Nov; 72(5):591-600. PubMed ID: 18949772
[TBL] [Abstract][Full Text] [Related]
39. Observational studies of drug-eluting stents--some are more equal than others.
Austin D; Oldroyd KG; Pell JP
EuroIntervention; 2009 Jan; 4(4):419, 421, 423. PubMed ID: 19284062
[No Abstract] [Full Text] [Related]
40. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting.
Chacko R; Mulhearn M; Novack V; Novack L; Mauri L; Cohen SA; Moses J; Leon MB; Cutlip DE
JACC Cardiovasc Interv; 2009 Jun; 2(6):498-503. PubMed ID: 19539252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
